This is not the most recent version of the article. View current version (10 NOV 2015)

Intervention Review

You have free access to this content

Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis

  1. Ian J Saldanha1,*,
  2. Oluwaseun Akinyede2,
  3. Karen A Robinson2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 9 DEC 2013

Assessed as up-to-date: 27 NOV 2013

DOI: 10.1002/14651858.CD009421.pub2


How to Cite

Saldanha IJ, Akinyede O, Robinson KA. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD009421. DOI: 10.1002/14651858.CD009421.pub2.

Author Information

  1. 1

    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD, USA

  2. 2

    Johns Hopkins University, Department of Medicine, Baltimore, MD, USA

*Ian J Saldanha, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Room E6014, Baltimore, MD, 21204, USA. isaldan1@jhmi.edu.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 9 DEC 2013

SEARCH

This is not the most recent version of the article. View current version (10 NOV 2015)

 
Characteristics of excluded studies [ordered by study ID]

StudyReason for exclusion

Bhorade 2011Unable to extract CF-specific information. Authors contacted, but no information received.

Iacono 2006Unable to extract CF-specific information. Authors contacted, but no information received.